Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human TrkA Reference Antibody (MNAC13, RUO) (HY107026)

Anti-Human TrkA Reference Antibody (MNAC13, RUO)
Anti-Human TrkA Reference Antibody (MNAC13, RUO)
Anti-Human TrkA Reference Antibody (MNAC13, RUO)
Anti-Human TrkA Reference Antibody (MNAC13, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HY107026
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHuman
IsotypeIgG
Clone IDMNAC13
Biological activity MNAC13 (200-300 ug/mL, 1 h) specifically binds TrkA and leads to inhibition of NGF-dependent signaling in 3T3 cells overexpressing TrkA [1]. MNAC13 (4 ug/mL, 4 days) effectively blocks NGF induced survival and axonal growth of PC12 cells [2]. MNAC13 (2 or 20 ng/mL) specifically binds to TrkA immune adhesin, but does not bind to TrkB in TrkA-BALB/C 3T3 cells [2]. Western Blot Analysis [1] Cell Line: 3T3 cells overexpressing TrkA Concentration: 200-300 ug/mL Incubation Time: 1 h Result: Significantly inhibited the phosphorylation of TrkA and the phosphorylation level of downstream signaling molecule PLCγ1. MNAC13 (0.9-60 ug; i.p. or s.c.; single dose; 18 h before the formalin test) significantly reduce inflammatory pain in the 5 % formalin solution injected CD1 male mice [1]. MNAC13 (30-70 ug; i.p.; once daily; from day 3 to day 10) significantly reduces neuropathic pain and exhibits long-lasting effects in the chronic constriction injury (CCI) CD1 male mice [1]. MNAC13 (1 ug; i.p.; single dose; 15 min before the test) has a significant synergistic analgesic effect combinated with opioid drugs in the 5 % formalin solution injected CD1 male mice [1]. MNAC13 blocks the effect of TrkA on basal forebrain cholinergic neurons (BFCNs) more significantly and persistently than blocking NGF in MNAC13 hybridoma cells injected Wistar rats [2].
Expression system Mammalian cells
Clonality Monoclonal
Target Trk-A, High affinity nerve growth factor receptor, NTRK1, Tropomyosin-related kinase A, Neurotrophic tyrosine kinase receptor type 1, MTC, TRKA, Tyrosine kinase receptor, TRK, p140-TrkA, TRK1-transforming tyrosine kinase protein, gp140trk, Tyrosine kinase receptor A
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P04629
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesMNAC13
Background

High affinity nerve growth factor receptor (NTRK1/TRKA) is a ~87 kDa protein. Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand. Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation.

1. Jing, S. et al. (1992) Neuron 9, 1067-79. PMID: 1281417
2. Tacconelli, A. et al. (2004) Cancer cell 6, 347-60. PMID: 15488758
3. Wehrman, T. et al. (2007) Neuron 53, 25-38. PMID: 17196528
4. Klein, R. et al. (1991) Cell 65, 189-97. PMID: 1849459
5. Hempstead, BL. et al. (1991) Nature 350, 678-83. PMID: 1850821
6. Tong, Q. et al. (2012) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 26, 3811-21. PMID: 22649032
7. Anta, B. et al. (2016) The Journal of biological chemistry 291, 19132-45. PMID: 27445338
8. Barker, PA. et al. (1993) The Journal of biological chemistry 268, 15150-7. PMID: 8325889
References 1. Ugolini G, et al. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2985-90. [HY107026]
2. Cattaneo A, et al. Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody. J Neurosci. 1999 Nov 15;19(22):9687-97. [HY107026]
Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Anti-Human TrkA Reference Antibody (MNAC13, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Anti-Human NTRK1/TRKA (MNAC13)

  • Anti-Human TrkA Reference Antibody (MNAC13, RUO)

    Bioactivity

    Detects recombinant NTRK1 (Catalog No: HY107012) in indirect ELISA.

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list